The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Novel therapeutic applications of cardiac glycosides
Abstract
Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit Na+/K+-ATPase. Members of this family have been in clinical use for many years for the treatment of heart failure and atrial arrhythmia, and the mechanism of their positive inotropic effect is well characterized. Exciting recent findings have suggested additional signalling modes of action of Na+/K+-ATPase, implicating cardiac glycosides in the regulation of several important cellular processes and highlighting potential new therapeutic roles for these compounds in various diseases. Perhaps most notably, the increased susceptibility of cancer cells to these compounds supports their potential use as cancer therapies, and the first generation of glycoside-based anticancer drugs are currently in clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The canonical activity of CGs is to inhibit the Na+, K+-ATPase 25 but other activities have been suggested to explain their pleiotropic effects 26.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [26]
Citations
Cites
1 retracted
Raghavendra, P. B., Sreenivasan, Y., Ramesh, G. T., & Manna, S. K. (2007) · APOPTOSIS · doi:10.1007/s10495-006-0626-3 · Cited by 50
RetractedWhy Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Calcium oscillations increase the efficiency and specificity of gene expression
Dolmetsch, R. E., Xu, K., & Lewis, R. S. (1998) · Nature · doi:10.1038/31960 · Cited by 1,893
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Kaplan, J. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102201.141218 · Cited by 1,181
Crystal structure of the sodium–potassium pump
Morth, J. P., Pedersen, B. P., Toustrup-Jensen, M. S., Sørensen, T. L.-M., Petersen, J., Andersen, J. P., Vilsen, B., & Nissen, P. (2007) · Nature · doi:10.1038/nature06419 · Cited by 951
Identification and characterization of a ouabain-like compound from human plasma.
Hamlyn, J. M., Blaustein, M. P., Bova, S., DuCharme, D. W., Harris, D. W., Mandel, F., Mathews, W. R., & Ludens, J. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6259 · Cited by 781
Na+/K+‐ATPase as a signal transducer
Xie, Z., & Askari, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02910.x · Cited by 592
Structure and Mechanism of Na,K-ATPase: Functional Sites and Their Interactions
Jorgensen, P. L., Håkansson, K. O., & Karlish, S. J. D. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142558 · Cited by 559
Cardiac Glycosides as Novel Cancer Therapeutic Agents
Newman, R. A., Yang, P., Pawlus, A. D., & Block, K. I. (2008) · Molecular Interventions · doi:10.1124/mi.8.1.8 · Cited by 515
Cited by
Autosis and autophagic cell death: the dark side of autophagy
Liu, Y., & Levine, B. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.143 · Cited by 742
Liu, Y., Shoji-Kawata, S., Sumpter, R. M., Wei, Y., Ginet, V., Zhang, L., Posner, B., Tran, K. A., Green, D. R., Xavier, R. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319661110 · Cited by 607
The Monarch Butterfly Genome Yields Insights into Long-Distance Migration
Zhan, S., Merlin, C., Boore, J. L., & Reppert, S. M. (2011) · Cell · doi:10.1016/j.cell.2011.09.052 · Cited by 588
Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
Huh, J. R., Leung, M. W. L., Huang, P., Ryan, D. A., Krout, M. R., Malapaka, R. R. V., Chow, J., Manel, N., Ciofani, M., Kim, S. V., et al. (2011) · Nature · doi:10.1038/nature09978 · Cited by 536
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
Barrows, N. J., Campos, R. K., Powell, S. T., Prasanth, K. R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Muñoz, G., McGrath, E. L., Urrabaz-Garza, R., Gao, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.004 · Cited by 497
Metadata
- Authors
- Prassas, I., & Diamandis, E. P.
- Affiliations
- University of Toronto (CA)
- Mount Sinai Hospital (CA)
- Corresponding author
- Diamandis, Eleftherios P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-10-24
- Volume
- 7
- Issue
- 11
- Pages
- 926-935
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2054405945
- Cited by
- 673
- References
- 134
- Citations by year
- 2026: 16 · 2025: 38 · 2024: 40 · 2023: 50 · 2022: 37 · 2021: 51 · 2020: 47 · 2019: 43 · 2018: 41 · 2017: 44 · 2016: 40 · 2015: 41 · 2014: 43 · 2013: 40 · 2012: 41
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Physical Sciences › Materials Science › Biomaterials › Phytochemistry and Bioactive Compounds
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- cardiac glycosides, Na+/K+-ATPase, signal transduction, heart failure, atrial arrhythmias, positive inotropic effect, anticancer agents, cancer therapy
- MeSH terms
- Sodium-Potassium-Exchanging ATPase, Animals, Antineoplastic Agents, Cardiac Glycosides, Clinical Trials as Topic, Heart Diseases, Humans, Neoplasms, Tumor Cells, Cultured, Molecular Structure, Apoptosis, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel therapeutic applications of cardiac glycosides. https://app.cochat.ai/papers/10.1038/nrd2682
- The paper
- Prassas, I., & Diamandis, E. P. (2008). Novel therapeutic applications of cardiac glycosides. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd2682
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.